關鍵數據
165.450今開
171.740最高
871.92K成交量
21.91本益比TTM
14.72本益比動
--股利TTM
1.13%換手率
165.530昨收
162.405最低
92.96M成交額
15.94本益比靜
1.35市淨率
0.00%股息率 TTM
3.56%ROA
211.00052週最高
0.65量比
791.47M淨利潤
77.15M總股本
7.4645每股盈餘TTM
1.26Beta
6.27%ROE
66.57052週最低
5.64%振幅
18.83%毛利率
12.62B總市值
-1.39回報/風險
3.14%風險率
操作建議
ICON PLC當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在生物技術與醫療研究行業排名58/385位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為187.27。中期看,股價處於上升通道。近一個月,市場表現一般,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
壓力支撐

由於公司未披露,未能獲取相關數據
ICON PLC新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Ionis Pharmaceuticals Inc
IONS
25
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
ICON PLC簡介
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
公司代碼ICLR
公司ICON PLC
CEOBalfe (Barry Edward)
網址https://www.iconplc.com/
公司股東
常見問題
ICON PLC(ICLR)的當前股價是 163.24。
ICON PLC股票的52週最高點是211.00。
現在ICON PLC(ICLR)的股票是買入、持有還是賣出?
根據分析師評級,ICON PLC(ICLR)的總體評級為買入,目標價格為187.27。
ICON PLC(ICLR)股票的每股收益(EPS TTM)是多少
ICON PLC(ICLR)股票的每股收益(EPS TTM)是2.92。